trial · primary record
STK-012
Advanced Solid Tumor
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 364 |
| Primary completion | 2029-01 |
| Primary endpoint | Phase 1a: Treatment emergent adverse events (TEAEs) |
| Registry ID | NCT05098132 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:35.555Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05098132
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.